Net profit of Balaxi Pharmaceuticals declined 94.22% to Rs 0.31 crore in the quarter ended December 2025 as against Rs 5.36 crore during the previous quarter ended December 2024. Sales declined 1.02% to Rs 72.54 crore in the quarter ended December 2025 as against Rs 73.29 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales72.5473.29 -1 OPM %4.265.44 - PBDT2.176.55 -67 PBT1.616.07 -73 NP0.315.36 -94 Powered by Capital Market - Live News

Net profit of Balaxi Pharmaceuticals declined 12.07% to Rs 1.53 crore in the quarter ended December 2025 as against Rs 1.74 crore during the previous quarter ended December 2024. Sales rose 120.34% to Rs 24.59 crore in the quarter ended December 2025 as against Rs 11.16 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales24.5911.16 120 OPM %5.610.81 - PBDT2.272.44 -7 PBT2.122.33 -9 NP1.531.74 -12 Powered by Capital Market - Live News

Balaxi Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 January 2026.Powered by Capital Market - Live News

Net profit of Balaxi Pharmaceuticals declined 95.42% to Rs 0.21 crore in the quarter ended September 2025 as against Rs 4.59 crore during the previous quarter ended September 2024. Sales declined 27.40% to Rs 56.18 crore in the quarter ended September 2025 as against Rs 77.38 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales56.1877.38 -27 OPM %2.0613.69 - PBDT1.866.03 -69 PBT1.385.56 -75 NP0.214.59 -95 Powered by Capital Market - Live News

Balaxi Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 11 November 2025.Powered by Capital Market - Live News